Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual ketamine wafers for pain during burn dressing changes
ACTRN12614000543684Phase 2Recruiting
- Sponsor
- iX Biopharma
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketamine in burn injury (2 arms), sponsored by iX Biopharma. Primary endpoint: Numerical rating scale for pain intensity. Started Apr 2014; status: recruiting.
02
Drugs
ketamine
03
Conditions
burn injury
Beyond the preview
Go deeper on ACTRN12614000543684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000543684.